{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T12:46:17Z","timestamp":1747226777982,"version":"3.40.5"},"reference-count":16,"publisher":"King Faisal Specialist Hospital and Research Centre","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Ann Saudi Med"],"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n          <jats:p>Adverse cutaneous reactions are rarely seen with antipsychotics. Exanthematous eruptions, skin pigmentation changes, photosensitivity, urticaria, and pruritus have been previously reported. We report a bruise-like rash in a 4-year-old boy with risperidone use. The rash disappeared on discontinuation and then reappeared after re-initiating the medication. Clinicians should be aware of a bruise-like skin rash as a rare adverse effect of risperidone. This is especially important for pediatric cases where physical abuse may be suspected.<\/jats:p>\n          <jats:sec>\n            <jats:title>SIMILAR CASES PUBLISHED:<\/jats:title>\n            <jats:p>None.<\/jats:p>\n          <\/jats:sec>","DOI":"10.5144\/0256-4947.2020.436","type":"journal-article","created":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T22:44:03Z","timestamp":1601678643000},"page":"436-438","source":"Crossref","is-referenced-by-count":0,"title":["Risperidone-induced bruise-like rash in a child"],"prefix":"10.5144","volume":"40","author":[{"given":"Ozalp","family":"Ekinci","sequence":"first","affiliation":[{"name":"From the Department of Child and Adolescent Psychiatry, University of Health Sciences and Medical Faculty, Istanbul, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8247-2145","authenticated-orcid":true,"given":"Serkan","family":"Gunes","sequence":"additional","affiliation":[{"name":"From the Department of Child and Adolescent Psychiatry, Hatay State Hospital, Hatay, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3134","reference":[{"key":"e_1_3_2_2_2","first-page":"38","article-title":"Rare Case Report of Rash Associated with Risperidone Long-Acting Injection.","volume":"17","author":"Sidhu K","year":"2010","journal-title":"Primary Psychiatry"},{"key":"e_1_3_2_3_2","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1176\/appi.ajp.160.6.1125","article-title":"Long-acting injectable risperidone: efficacy and safety of the first long-acting atypical antipsychotic.","volume":"160","author":"Kane JM","year":"2003","journal-title":"Am J Psychiatry"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.euroneuro.2004.07.003","article-title":"Comparative efficacy and safety of long-acting risperidone and risperidone oral tablets.","volume":"15","author":"Chue P","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"key":"e_1_3_2_5_2","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2165\/00128071-200203090-00005","article-title":"Adverse cutaneous reactions to antipsychotics.","volume":"3","author":"Warnock JK","year":"2002","journal-title":"Am J Clin Dermatol"},{"key":"e_1_3_2_6_2","first-page":"251","article-title":"Oculotoxic and dermatotoxic side effects of phenothiazines.","volume":"49","author":"Garenfeld W","year":"2007","journal-title":"Tijdschr Psychiatr"},{"key":"e_1_3_2_7_2","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/j.1398-9995.1998.tb03962.x","article-title":"Contact dermatitis to chlorprothixene.","volume":"53","author":"Lepp U","year":"1998","journal-title":"Allergy"},{"key":"e_1_3_2_8_2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.14712\/18059694.2017.114","article-title":"Acute generalized exanthematous pustulosis induced by olanzapine.","volume":"49","author":"Christen S","year":"2006","journal-title":"Acta Medica (Hradec Kralove)"},{"key":"e_1_3_2_9_2","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1365-4632.2004.02255.x","article-title":"Skin hyperpigmentation induced by olanzapine, a novel antipsychotic agent.","volume":"43","author":"Jhirwal OP","year":"2004","journal-title":"Int J Dermatol"},{"key":"e_1_3_2_10_2","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1345\/aph.19038","article-title":"Papular rash and bilateral pleural effusion associated with clozapine.","volume":"33","author":"Stanislav SW","year":"1999","journal-title":"Ann Pharmacother"},{"key":"e_1_3_2_11_2","first-page":"178","article-title":"The clinical use of risperidone in child & adolescent psychiatry.","volume":"1","author":"Kim BN","year":"2003","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"e_1_3_2_12_2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.4103\/0019-5545.174407","article-title":"Risperidone-induced skin rash.","volume":"58","author":"Janardhana P","year":"2016","journal-title":"Indian J Psychiatry"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","first-page":"414","DOI":"10.4088\/PCC.v10n0511e","article-title":"Rash and desquamation associated with risperidone oral solution.","volume":"10","author":"Chae BJ","year":"2008","journal-title":"Prim Care Companion J Clin Psychiatry"},{"key":"e_1_3_2_14_2","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1365-2125.2007.02909.x","article-title":"Risperidone-induced recurrent giant urticaria.","volume":"64","author":"Mishra B","year":"2007","journal-title":"Br J Clin Pharmacol"},{"key":"e_1_3_2_15_2","doi-asserted-by":"crossref","first-page":"33","DOI":"10.5350\/KPB-BCP201121106","article-title":"Risperidone Treatment in Preschool Children with Disruptive Behavior Disorders: A Chart Review Study.","volume":"21","author":"Coskun M","year":"2011","journal-title":"Bulletin of Clinical Psycho-pharmacology"},{"key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1365-2125.2006.02708.x","article-title":"Risperidone-induced erythema multiforma min\u00f6r.","volume":"62","author":"Desarder P","year":"2006","journal-title":"Br J Clin Pharmacol"},{"key":"e_1_3_2_17_2","doi-asserted-by":"crossref","first-page":"940","DOI":"10.4088\/JCP.v65n0710","article-title":"Changes in serum inter-leukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia.","volume":"65","author":"Zhang XY","year":"2004","journal-title":"J Clin Psychiatry"}],"container-title":["Annals of Saudi Medicine"],"original-title":[],"language":"en","deposited":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T22:46:10Z","timestamp":1601678770000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.annsaudimed.net\/doi\/10.5144\/0256-4947.2020.436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":16,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["10.5144\/0256-4947.2020.436"],"URL":"https:\/\/doi.org\/10.5144\/0256-4947.2020.436","relation":{},"ISSN":["0256-4947","0975-4466"],"issn-type":[{"type":"print","value":"0256-4947"},{"type":"electronic","value":"0975-4466"}],"subject":[],"published":{"date-parts":[[2020,9]]}}}